Photo: Hindustan Times
Human Trials Of mRNA, India's Vaccine Against Omicron To Begin In February
Human trials of mRNA vaccine against COVID-19's new variant Omicron is to begin from February. Notably, Pune-based Gennova Biopharmaceutical made mRNA vaccine and completed phase I and II trials and submitted a report to the Drugs Controller General of India (DCGI). Along with it, the company also submitted a data of Phase III trials and are waiting for their approval from the Vaccine Subject Expert Committee (SEC).
Tags: mRNA, Omicron Vaccine, Gennova biopharmaceutical, Covid-19, DCGI
Courtesy: The Times Of India
Photo: Business Today
Russia To Modify Sputnik V Vaccine For Omicron Variant
Russia's Gamaleya Institute, the developer of the Sputnik V vaccine, has started developing a modified version of the vaccine for the COVID-19 Omicron variant. It's planned to start the mass-scale production of the updated vaccine in 45 days. However, the institute also believes that Sputnik V and Sputnik Light are also effective against the new variant. Notably, the Omicron variant was first detected in South Africa last week.
Tags: Russia, Sputnik V, omicron, Covid-19 Vaccine, Omicron Vaccine
Courtesy: ETV Bharat
